The senolyitc drug ABT-263 reverses HFpEF-associated inflammation, endothelial inflammation and fibrosis
30 June 2021 (14:00 - 15:00)
Organised by:
About the speaker

I3s (Institute for Research and Innovation in Health), Porto (Portugal)
9 More presentations in this session

Doctor C. Lam (Singapore, SG)
Access the full session
The Event
Heart Failure 2021
30 June 2021
14:00 CET






